• Podophyllotoxin Workflows for Cancer Cell Studies

  2026-09-01

  Podophyllotoxin provides a practical microtubule-directed system for studying mitotic arrest, apoptosis, and stress-linked autophagy in cancer models. This guide separates parent-compound biology from derivative-specific findings and translates the latest multidrug-resistance research into reproducible assay choices.

• Isoproterenol Sulfate Dihydrate in Pacemaker Research

  2026-08-31

  Isoproterenol sulfate dihydrate is a water-soluble Isoproterenol hemisulfate salt used to stimulate beta-adrenergic receptor signaling in cardiovascular and respiratory research. In human SAN-plexus assembloids, it is best used as an acute pharmacological perturbation tool rather than as a replacement for intrinsic neural maturation.

• BFH772 (VEGFR2 inhibitor): Workflow Guide

  2026-08-31

  BFH772 is a selective small-molecule VEGFR2 inhibitor for biochemical, cellular, and tumor angiogenesis research where controlled VEGFR2 modulation is required. Its organic-solvent solubility and water insolubility make it unsuitable for workflows requiring direct aqueous formulation or broad-spectrum kinase inhibition.

• Cyanin Chloride in a Human Psoriasis Cell Model

  2026-08-30

  The 2024 reference study shows that cyanin chloride, a glycosylated cyanidin derivative, suppresses inflammatory signaling and improves barrier-associated responses in cytokine-stimulated HaCaT keratinocytes. Its combined use of antioxidant, macrophage, transcriptional, signaling, and barrier assays provides a useful framework for evaluating anthocyanin-related mechanisms, while the distinction between cyanin chloride and Cyanidin Chloride remains essential for experimental interpretation.

• Frizzled5 Couples Cholesterol to Wnt Signaling

  2026-08-29

  The reference study identifies Frizzled5 as a cholesterol-sensing Wnt receptor and shows how cholesterol binding promotes receptor palmitoylation, maturation, and signaling in Wnt-dependent pancreatic cancer. Its experimental framework separates lipid binding, receptor trafficking, pathway activation, and tumor-growth effects, providing a useful model for studying metabolic control of oncogenic signaling.

• Ceftazidime as a Gene-to-Phenotype Probe

  2026-08-29

  Ceftazidime is a third-generation cephalosporin with particular value in Pseudomonas aeruginosa and Gram-negative bacterial infection research. This article explains how to use its phenotype alongside carbapenemase-gene location, plasmid transfer, and epidemiologic data rather than treating susceptibility as a standalone result.

• Metformin Hydrochloride in Vocal Fold Fibrosis

  2026-08-28

  Metformin Hydrochloride is more than a glucose-regulation tool: emerging evidence positions it as a probe of the AMPK–TGF-β axis in vocal fold fibrosis. This guide translates rabbit and fibroblast findings into practical assay, control, formulation, and interpretation decisions.

• ML133 HCl for Kir2.1 Research

  2026-08-28

  ML133 HCl is a selective potassium channel inhibitor for separating Kir2.1-dependent potassium ion transport from downstream vascular remodeling signals. This practical guide covers pH-aware dosing, PASMC assays, comparative controls, and troubleshooting for reproducible cardiovascular ion channel research.

• Amyloid β-Peptide (1-42): Assay Interpretation

  2026-08-27

  Amyloid β-Peptide (1-42) is more than a generic neurotoxicity reagent: its aggregation state, cellular context, and endpoint selection shape biological interpretation. This article integrates mechanistic biology, product handling, and evidence from SH-SY5Y and APP-model research to improve Aβ42 peptide assay decisions.

• Thioguanine Workflows for Cancer and Viral Assays

  2026-08-27

  Build more reproducible 6-thioguanine experiments with practical stock-preparation, dose–response, HGPRT-selection, and antiviral assay guidance. The workflow separates compound-specific biology from assay artifacts while connecting cancer cell proliferation inhibition, EV71 virus inhibition, and DNMT1-focused validation.

• RNA Polymerase II Degradation and Cell Death

  2026-08-26

  The preprint argues that degradation of RNA polymerase II can activate cell death through a mechanism that is not simply a consequence of transcriptional shutdown. Its causal framework encourages researchers to separate loss of transcription from the biological effects of eliminating the Pol II protein itself when designing mechanistic cell-death studies.

• 1-Myristoylglycerophosphocholine: Signaling & Fibrosis

  2026-08-26

  1-myristoylglycerophosphocholine, also called 14:0 Lyso-PC, is a monoacyl phosphatidylcholine used to study lipid signaling, smooth muscle responses, and pulmonary fibrosis mechanisms. Yang et al. linked LysoPC release from injured alveolar epithelial cells to fibroblast activation, while product-specific receptor attribution remains an experimental question.

• PDHA1, Cuproptosis, and Enzalutamide Resistance

  2026-08-25

  This 2026 Cell Death and Disease study identifies PDHA1-driven acetyl-CoA and histone acetylation as a metabolic-epigenetic circuit that suppresses cuproptosis and weakens enzalutamide activity in castration-resistant prostate cancer. Its findings connect mitochondrial carbon metabolism with SLC7A11, glutathione, copper handling, and treatment resistance, while supporting PDHA1 targeting as a strategy for restoring drug sensitivity.

• Puromycin Aminonucleoside for Podocyte Injury Models

  2026-08-25

  Puromycin aminonucleoside provides a controllable route to podocyte damage, proteinuria, and glomerular pathology in cell and animal studies. This workflow-focused guide covers preparation, assay design, transporter-aware optimization, and troubleshooting for nephrotic injury research.

• Polyphenol-Armored Nanogene for Aged OA

  2026-08-24

  This Advanced Science study develops a catechol-adhesive hydrogel that retains polyphenol-armored, miR-140-loaded nanoparticles in osteoarthritic joints. The integrated platform addresses RNA instability, delivery barriers, oxidative stress, and chondrocyte senescence, while showing therapeutic benefit in an aged rat model.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page